Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 1941962)

Published in Clin Exp Immunol on June 21, 2007

Authors

C B Hicks1, C Gay, G Ferrari

Author Affiliations

1: Duke University Medical Center, Department of Medicine, Durham, North Carolina 27710, USA.

Associated clinical trials:

Research In Viral Eradication of HIV Reservoirs (RIVER) | NCT02336074

Articles cited by this

Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med (2006) 24.38

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol (1994) 22.96

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 20.00

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood (2006) 17.38

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol (1994) 15.93

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (1993) 15.54

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med (2004) 13.55

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med (2006) 13.15

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature (2005) 13.15

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature (2005) 11.12

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol (2002) 10.37

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature (2003) 10.16

HIV preferentially infects HIV-specific CD4+ T cells. Nature (2002) 9.28

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med (2004) 9.11

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med (2006) 8.18

Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol (2003) 8.02

Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature (2001) 7.90

High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis (2007) 7.70

Immune control of HIV-1 after early treatment of acute infection. Nature (2000) 7.68

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA (2006) 7.49

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med (2000) 5.79

T cell dynamics in HIV-1 infection. Annu Rev Immunol (2001) 5.29

HIV disease: fallout from a mucosal catastrophe? Nat Immunol (2006) 5.08

Acute human immunodeficiency virus type 1 infection. N Engl J Med (1998) 5.04

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med (2001) 4.42

Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol (2006) 3.80

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci U S A (2000) 3.66

HLA and AIDS: a cautionary tale. Trends Mol Med (2001) 3.51

Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med (1994) 3.20

Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med (2006) 3.09

AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med (2005) 2.97

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis (2006) 2.88

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol (1996) 2.51

Limited durability of viral control following treated acute HIV infection. PLoS Med (2004) 2.16

Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS (2000) 2.08

Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med (1997) 2.03

Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis (2005) 1.95

Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis (2007) 1.91

Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. J Infect Dis (2006) 1.42

Immunological correlates of protection from HIV infection and disease. Nat Immunol (2006) 1.40

Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J Infect Dis (1998) 1.39

Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. J Infect Dis (1999) 1.28

Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection. J Virol (2001) 1.27

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. J Infect Dis (2003) 1.27

Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J Immunol (2003) 1.25

High frequencies of antibody responses to CD4 induced epitopes in HIV infected patients started on HAART during acute infection. Hum Antibodies (2005) 1.18

The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cells. J Immunol (2007) 1.18

Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis (1993) 1.17

Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions. AIDS (2005) 1.06

Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study. Lancet (1998) 1.05

Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters. J Acquir Immune Defic Syndr (2003) 0.99

Current concepts of HIV transmission. Curr HIV/AIDS Rep (2007) 0.93

Treatment of acute HIV-1 infection: is it coming of age? J Infect Dis (2006) 0.85

Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection. J Acquir Immune Defic Syndr (2004) 0.85

Articles by these authors

(truncated to the top 100)

A concise guide to cDNA microarray analysis. Biotechniques (2000) 8.36

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science (1997) 4.58

Changes in antimicrobial resistance among Salmonella enterica Serovar typhimurium isolates from humans and cattle in the Northwestern United States, 1982-1997. Emerg Infect Dis (2000) 3.32

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science (1995) 2.79

Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71

Electric-field-induced capillary attraction between like-charged particles at liquid interfaces. Nature (2002) 2.21

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med (1991) 2.11

Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology (2005) 2.01

The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology (1989) 1.93

Force response of a viscous liquid in a probe-tack geometry: fingering versus cavitation. Eur Phys J E Soft Matter (2004) 1.85

T cell assays and MIATA: the essential minimum for maximum impact. Immunity (2012) 1.74

Highly efficient production and characterization of T-DNA plants for rice ( Oryza sativa L.) functional genomics. Theor Appl Genet (2003) 1.66

Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. Hum Gene Ther (1999) 1.66

Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation. J Neurol Neurosurg Psychiatry (2010) 1.62

Safety of retroviral gene marking with a truncated NGF receptor. Nat Med (2003) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J Neurosci (1997) 1.54

Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults. AIDS Res Hum Retroviruses (2006) 1.47

Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood (1994) 1.45

Clonal analysis of stably transduced human epidermal stem cells in culture. Proc Natl Acad Sci U S A (1996) 1.44

Tetracycline compound placement to prevent dry socket: a postoperative study of 200 impacted mandibular third molars. J Oral Maxillofac Surg (2004) 1.44

Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology (2003) 1.43

High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J Clin Invest (1998) 1.43

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res (2001) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Regulation of base balance in bicarbonate hemofiltration. Int J Artif Organs (1994) 1.38

Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunol Immunother (2009) 1.36

CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proc Natl Acad Sci U S A (2000) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Formation of a matter-wave bright soliton. Science (2002) 1.27

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc Natl Acad Sci U S A (1999) 1.27

Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr Drug Metab (2007) 1.26

Stimulation of 45Ca efflux from smooth muscle cells by metabolic inhibition and high K depolarization. Pflugers Arch (1975) 1.24

Mental, physical and functional status in primary care attenders. Int J Psychiatry Med (1999) 1.21

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication. J Infect Dis (1995) 1.19

Nerve growth factor activates Thy-1 and neurofilament gene transcription in rat PC12 cells. EMBO J (1986) 1.19

alpha2-chimaerin, a Cdc42/Rac1 regulator, is selectively expressed in the rat embryonic nervous system and is involved in neuritogenesis in N1E-115 neuroblastoma cells. J Neurosci (2001) 1.15

Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency. J Natl Cancer Inst (1993) 1.14

Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13

Identification of Culicoides obsoletus (Diptera: Ceratopogonidae) as a vector of bluetongue virus in central Italy. Vet Rec (2005) 1.11

Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int (1988) 1.11

In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J Virol (1992) 1.11

Pleural tuberculosis and human immunodeficiency virus co-infection. Int J Tuberc Lung Dis (1997) 1.10

Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia (1990) 1.10

Imaging of pyelonephritis. Pediatr Radiol (1997) 1.09

Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07

Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07

Continuous positive airway pressure and nasal inflammation patterns in obstructive sleep apnea: anti-inflammatory or proinflammatory? Sleep Med (2013) 1.06

Paraparesis in hereditary multiple exostoses: case report. Neurology (1979) 1.05

Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05

N-acetylcysteine-promoted survival of PC12 cells is glutathione-independent but transcription-dependent. J Biol Chem (1995) 1.04

gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants. J Virol (1998) 1.04

[Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?]. Gynecol Obstet Fertil (2009) 1.03

Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02

Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and Molecular Mechanisms Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol (1996) 1.02

Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum Gene Ther (1993) 1.01

Public anatomy lessons and the carnival: the anatomy theatre of Bologna. Past Present (1987) 1.01

Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes (1992) 1.01

Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. AIDS Res Hum Retroviruses (2000) 1.00

Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00

Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99

Oral hygiene and postoperative pain after mandibular third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 0.99

Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn Mol Pathol (1999) 0.99

Mechanism of sulfate transport inhibition by cycloheximide in plant tissues. Plant Physiol (1975) 0.98

Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells. J Cell Sci (1995) 0.98

Dominant inhibitory Ras delays Sindbis virus-induced apoptosis in neuronal cells. J Virol (1996) 0.97

Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells. Blood (1999) 0.96

POLG1 in idiopathic Parkinson disease. Neurology (2006) 0.96

Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96

Surgical treatment and prognostic variables of hepatocellular carcinoma in 122 cirrhotics. Hepatogastroenterology (1995) 0.95

An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol (1994) 0.95

Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett (2007) 0.95

N-acetylaspartic aciduria: report of three new cases in children with a neurological syndrome associating macrocephaly and leukodystrophy. J Inherit Metab Dis (1988) 0.95

Mirtazapine in the treatment of panic disorder: an open-label trial. Int Clin Psychopharmacol (2003) 0.95

Gangliosides enhance neurite outgrowth in PC12 cells. Brain Res (1983) 0.95

Measurement of the strong coupling constant from inclusive jet production at the Tevatron pp collider. Phys Rev Lett (2002) 0.94

Combination treatment versus LHRH alone in advanced prostatic cancer. Urol Int (1996) 0.94

Etoposide induces the dispersal of DNA ligase I from replication factories. Mol Biol Cell (2001) 0.94

Development of Sulfate Uptake Capacity and ATP-Sulfurylase Activity during Root Elongation in Maize. Plant Physiol (1977) 0.94

X-linked olivopontocerebellar atrophy. Clin Genet (1989) 0.94

Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability. Mol Vis (2009) 0.93

Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci Lett (1999) 0.93

Search for gluinos and scalar quarks in pp collisions at square root[s] = 1.8 TeV using the missing energy plus multijets signature. Phys Rev Lett (2002) 0.93

Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum Gene Ther (1997) 0.93

A first report of collagenous gastritis, sprue, and colitis in a 9-month-old infant: 14 years of clinical, endoscopic, and histologic follow-up. Endoscopy (2009) 0.92

Frozen thin-sections of rapidly forming bone: bone cell ultrastructure. Calcif Tissue Res (1975) 0.92

Nanoscale capacitance imaging with attofarad resolution using ac current sensing atomic force microscopy. Nanotechnology (2006) 0.91

[Isolated oculomotor palsy disclosing multiple myeloma]. J Fr Ophtalmol (1995) 0.90

Search for Z' --> e+ e- using dielectron mass and angular distribution. Phys Rev Lett (2006) 0.90

Tetanus toxin receptor. Specific cross-linking of tetanus toxin to a protein of NGF-differentiated PC 12 cells. FEBS Lett (1991) 0.90

DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation. Transpl Infect Dis (2014) 0.89

Compact high-flux source of cold sodium atoms. Rev Sci Instrum (2013) 0.89

Effect of pancreas transplantation on life expectancy, kidney function and quality of life in uraemic type 1 (insulin-dependent) diabetic patients. Diabetologia (1991) 0.89

CD40 signalling in ileal Peyer's patch B cells: implications for T cell-dependent antigen selection. Int Immunol (1995) 0.89

Coherent delocalization of atomic wave packets in driven lattice potentials. Phys Rev Lett (2008) 0.89